Immunotherapy of non-Hodgkin's lymphoma with hLL2 (epratuzumab, an anti-CD22 monoclonal antibody) and Hu1D10 (apolizumab).
(Q34528379)
scientific article
scientific article
Language:
Current Data About
Immunotherapy of non-Hodgkin's lymphoma with hLL2 (epratuzumab, an anti-CD22 monoclonal antibody) and Hu1D10 (apolizumab).
| (P31) |
(Q13442814)
|
||||||||||||||||
| (P304) |
81-86
|
||||||||||||||||
| (P433) |
1 Suppl 2
|
||||||||||||||||
| (P478) |
29
|
||||||||||||||||
| (P577) |
Friday, February 1, 2002
|
||||||||||||||||
| (P921) |
(Q79460)
(Q1427096)
(Q422248)
|
||||||||||||||||
| (P1433) |
(Q14330412)
|
||||||||||||||||
| (P1476) |
"Immunotherapy of non-Hodgkin's lymphoma with hLL2 (epratuzumab, an anti-CD22 monoclonal antibody) and Hu1D10 (apolizumab)." (language: en)
|
||||||||||||||||
| (P2093) |
John P Leonard
Brian K Link
|
||||||||||||||||
| (P13046) |
(Q7318358)
|